AzTrials
AzTrials

AmputationNCT07011420

Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control

A study testing Experimental socket with 4 untargeted channels active, Experimental socket with 8 untargeted channels active and Experimental socket with up to 16 untargeted channels active in people with Amputation and Amputation, Traumatic, run by Liberating Technologies, Inc. at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to systematically evaluate whether or not two commonly held fundamental assumptions for pattern recognition control translates to functional performance when tested on individuals aged 18 years or older with upper limb absence at the transradial level while wearing a physical… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Experimental socket with 4 untargeted channels active, Experimental socket with 8 untargeted channels active and Experimental socket with up to 16 untargeted channels active
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
2 sitesUnited States
Study dates
Oct 2025to Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Unilateral transradial level limb absence
  • Current or past user of myo-electric controlled prostheses
  • Six months or more post-amputation
  • Have adequate limb length such that a wrist rotation device can fit in the check socket
  • Well-fitting socket as determined by a Socket-Comfort Score of 6 or above
  • Capable of wearing and operating a prosthesis with a wrist rotator and multi-articulating hand
  • Capable of understanding and following multi-step instructions and completing the tasks as described
  • English speaking

Who cannot join

  • Significant new injury that would prevent use of a prosthesis: The ability to consistently wear a prosthesis and perform activities of daily living and specific performance tasks is necessary to evaluate the relative benefits of the interventions.
  • Cognitive impairment sufficient to adversely affect understanding of or compliance with study requirements, ability to communicate experiences, or ability to give informed consent: The ability to understand and comply with requirements of the study is essential for the study to generate useable, reliable data. The ability to obtain relevant user feedback through questionnaires and informal discussion adds significant value to this study.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States2 sites, 2 recruiting
  • Shirley Ryan AbilityLab

    Chicago, Illinois, 60611

    Laura Miller, PhD, 312-238-1000, lmiller1@sralab.org

    Recruiting
  • Liberating Technologies, Inc.

    Holliston, Massachusetts, 01746

    Brianna Rozell, 774-233-0876, brianna.rozell@liberatingtech.com

    Not yet recruiting

Other trials in United States

About this study

Official title: Evaluation of Functional Performance of Persons With Limb Differences to Optimize Pattern Recognition Control of Powered Upper Limb Prosthesis

The goal of this clinical trial is to systematically evaluate whether or not two commonly held fundamental assumptions for pattern recognition control translates to functional performance when tested on individuals aged 18 years or older with upper limb absence at the transradial level while wearing a physical prosthesis.

The specific aims of this study are:

Read more
  1. To evaluate the effect of changing untargeted myoelectric channel count on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the Box and Blocks test.
  2. To evaluate the effect of changing myoelectric channel targeting of a fixed number of myoelectric channels on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the Box and Blocks test.

Researchers will perform a randomized crossover study to compare system configurations with different number of sensor channels and with various strategies for sensor placement on the limb. Participants will be assigned to a random test sequence that includes the following four different EMG channel conditions:

Condition A: 4 untargeted channels Condition B: 8 untargeted channels Condition C: Up to 16 untargeted channels Condition D: 8 targeted channels

Researchers will evaluate the effects of changing myoelectric channel counts on the functional prosthesis performance of individuals with transradial limb loss via functional outcome measures.

Participants will:

  • Attend up to 5 in-lab sessions that are expected to last 4 hours.
  • Conduct site visits every 1-2 weeks to complete functional and self reported outcome measures with each condition.
  • Play virtual games with the Coapt Cuff for 15 minutes a day, 3 days a week in between visits.
Read the detailed description

The objective of this study is to systematically evaluate whether or not two commonly held fundamental assumptions for pattern recognition control, that have been established nearly exclusively on offline data analysis from able-bodied subjects, translates to functional performance when tested on persons with upper limb difference wearing a physical prosthesis.

The two prior assumptions that will be evaluated are: 1) there is no advantage to targeting myoelectric channels to specific muscle sites, and 2) there is no advantage to using more than 4-6 myoelectric channels for trans-radial prosthesis users.

The investigators will perform a randomized crossover study to compare system configurations with different number of sensor channels and with various strategies for sensor placement on the limb. Unlike much of the existing research, this study will test these configurations with subjects with limb absence controlling physical prosthetic arms to directly conduct activities of daily living.

The specific aims of this study are:

  1. To evaluate the effect of changing untargeted myoelectric channel count on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the AMULA, ACMC, and Clothespin relocation tests (described below).
  2. To evaluate the effect of changing myoelectric channel targeting of a fixed number of myoelectric channels on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the AMULA, ACMC, and Clothespin relocation tests.

Experimental check sockets will be made for each participant. Two sockets will be made (one with targeted channels and another with untargeted channels). Sockets are for in lab use only. The Coapt Pattern Recognition control system, including Coapt Gen1 and Coapt Gen2 hardware, will be used for this study. Coapt control system is a clinically focused software application interface with channel selection, control calibration tools, and a gaming interface. A Coapt EMG Cuff will be provided for home use.

Commercial prosthetic components are from multiple manufacturers. Commercial wrist units include devices such as the Motion Control wrist rotator. Commercial hand units include devices such as the TASKA CX Hand. These listed devices are commercially available.

Once the subject has provided consent, they will be assigned to a random test sequence that includes the following four different EMG channel conditions.

Condition A: 4 untargeted channels Condition B: 8 untargeted channels Condition C: Up to 16 untargeted channels Condition D: 8 targeted channels

Block randomization based on random number generation will be used to equally distribute the 32 subjects into the 4 possible intervention sequences of the Williams design (e.g., ABDC, BCAD, CDBA, and DACB). The order of completion of the condition sequences will be randomized, each visit will involve completing training and testing for the specific assigned condition.

Participants will attend up to 5 in-lab sessions that are expected to last 4 hours. Participants will be monitored during all sessions and will be allowed to take breaks at any time during training and testing as needed. Additional in-lab sessions may be scheduled if any issues arise during the visit (time constraints, issues with completing or recording the intended data from the visit, subjects gets too fatigued to complete the protocol, etc).

During the first visit, the socket will either be duplicated or a cast will be taken to fabricate two experimental sockets, one with targeted electrode locations and another with non-targeted electrode locations. The first socket will follow Coapt's clinical instructions for targeted site location to identify and mark locations for 8 targeted EMG channels (Condition D). Untargeted sites, for the second socket, will ideally be located by creating a band of electrode pairs at the largest muscular circumference distal to the elbow. Three untargeted channel conditions will be evaluated. One will use the full set of 16 channels (Condition C). The 4-channel untargeted condition (Condition A) will utilize every fourth channel, and their location will be targeted at positions that are 'on the 45s' when examining a cross section of the forearm with the elbow bent to 90 degrees and the thumb pointed up (blue-colored channels. The 8-channel condition (Condition B) will use the same channels as the 4-channel condition but add the four channels that bisect the original four channels (blue and orange colored channels. Due to different limb sizes a full singular ring of 16 channels may not be possible on all human subjects. In these situations, the clinicians fabricating will use their best clinical judgement in order to fit as many electrode channels as possible onto the arm.

During the first visit, participants will also be fit with a Coapt EMG Cuff for at-home use between the visits. During visits 2-5, participants will don the appropriate socket for the condition being tested and connect to the Coapt software. Participants will run through the coapt calibration procedure and conduct training with the study team OT which will be similar to training received as standard of care when receiving a new prosthetic device. Participants will then conduct a series of functional outcome measures designed for upper limb prosthesis users such as the Assessment for the Capacity for Myoelectric Control (ACMC), Activities Measure for Upper Limb Amputees (AMULA), and the Clothespin Relocation Test. Subjects may also be asked to complete virtual games within the Coapt software and complete custom surveys about their experiences with the control configuration during that testing session. Additionally, subjects will be asked to answer custom surveys about their experiences with the control configuration during that testing session, such as "rate how responsive the device was to your intended movements on a scale of 1-10." The participant will then go home for approximately 1-2 weeks. When they return for their next visit, they will follow the randomized order of test conditions and repeat training and testing described above for the specific assigned condition.

Between visits, participants will be sent home with the EMG Cuff and a tablet that will allow them to use the Coapt software to practice using pattern recognition control in a virtual environment. Participants will be asked to play virtual games for 15 minutes a day, 3 days a week between visits. The time between visits is expected to be about 1-2 weeks. The goal of the games is to strengthen the participant's ability to isolate individual motions, understand the intensity of their muscle contractions, to improve control in their muscle contraction intensity to better utilize proportional speed when controlling a prosthesis.

Being tested
Experimental socket with 4 untargeted channels active, Experimental socket with 8 untargeted channels active, Experimental socket with up to 16 untargeted channels active, Experimental socket with 8 targeted channels active, Coapt EMG Cuff
Keywords
amputee, upper limb amputee, transradial amputee, prosthetic arm, upper limb prosthesis user
Medical subject headings
Amputation, Traumatic, Amputation, Congenital, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental socket with 4 untargeted channels activeDevice

    Participants will utilize the experimental socket made with untargeted EMG channels. Untargeted sites will ideally be located by creating a band of electrode pairs at the largest muscular circumference distal to the elbow. Only 4 channels will be active during this condition.

  • Experimental socket with 8 untargeted channels activeDevice

    Participants will utilize the experimental socket made with untargeted EMG channels. Untargeted sites will ideally be located by creating a band of electrode pairs at the largest muscular circumference distal to the elbow. Only 8 channels will be active during this condition.

  • Experimental socket with up to 16 untargeted channels activeDevice

    Participants will utilize the experimental socket made with untargeted EMG channels. Untargeted sites will ideally be located by creating a band of electrode pairs at the largest muscular circumference distal to the elbow. All16 channels (or the maximum number of channels based on limb size) will be active during this condition.

  • Experimental socket with 8 targeted channels activeDevice

    Participants will utilize the experimental socket made with targeted EMG channels. This socket will follow Coapt's clinical instructions for targeted site location to identify and mark locations for 8 targeted EMG channels.

  • Coapt EMG CuffDevice

    This device is the commercially available Coapt EMG Cuff. This armband cuff with electrodes can be strapped onto the user's arm to connect with the Coapt app and play virtual games with their EMG signals.

Study groups in NCT07011420
Study groupRoleWhat they receive
Condition A: 4 untargeted channelsExperimentalThe 4-channel untargeted condition (Condition A) will utilize every fourth channel, and their location will be targeted at positions that are 'on the 45s' when examining a cross section of the forearm with the elbow bent to 90 degrees and the thumb pointed up. This condition is conducted and completed during a site visit. Outcome measures will be conducted to assess functional outcomes and self-report measures.
Receives: Device: Experimental socket with 4 untargeted channels active
Condition B: 8 untargeted channelsExperimentalThe 8-channel condition (Condition B) will use the same channels as the 4-channel condition but add the four channels that bisect the original four channels. This condition is conducted and completed during a site visit. Outcome measures will be conducted to assess functional outcomes and self-report measures.
Receives: Device: Experimental socket with 8 untargeted channels active
Condition C: Up to 16 untargeted channelsExperimentalThe 16-channel untargeted condition (Condition C) will utilize all 16 electrodes. Due to different limb sizes a full singular ring of 16 channels may not be possible on all human subjects. In these situations, the clinicians fabricating will use their best clinical judgement in order to fit as many electrode channels as possible onto the arm. If there is no reasonable way to fit 16 channels within the socket, then the maximum possible number of channels will be placed in the socket and the "16-channel" condition will be completed with the maximum number of available channels. This condition is conducted and completed during a site visit. Outcome measures will be conducted to assess functional outcomes and self-report measures.
Receives: Device: Experimental socket with up to 16 untargeted channels active
Condition D: 8 targeted channelsActive comparatorThis socket will use 8 targeted EMG channels identified and marked by the study prosthetist using Coapt's clinical instructions for identifying electrode sites. This condition is conducted and completed during a site visit. Outcome measures will be conducted to assess functional outcomes and self-report measures.
Receives: Device: Experimental socket with 8 targeted channels active
At-home Pattern Recognition PracticeOtherThe subject will use a commercially available EMG Coapt Cuff to practice pattern recognition while at home between study visits. They will be asked to play virtual games with the Coapt Cuff for 15 minutes a day, 3 days a week in between visits. The time between visits will be based on scheduling availability of the participant and study team but is expected to be approximately 1-2 weeks.
Receives: Device: Coapt EMG Cuff

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Assessment of Capacity for Myoelectric Control (ACMC)

    The ACMC is a performance-based assessment where trained raters observe the user performing a task and rate their ability to control specific hand movements. These movements are rated on a 4-point scale, ranging from "not capable" to "spontaneously capable". 0 = Not capable. 1 = Sometimes capable, capacity not established. 2 = Capable on request. 3 = Spontaneously capable.

    The items comprising the ACMC describe different levels of difficulty of control of the myoelectric hand. The items are grouped into 4 categories: gripping, holding, releasing, and coordinating between hands. The task that will be done for our study is packing a suitcase for a weekend trip. A higher score corresponds with a greater ability to control a myoelectric hand.

    This assessment will be done for each condition, each of which will be tested in visits 2-5.

    Measured: 4 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2025
  2. Study startOct 2025 (estimated)
  3. Primary completionJun 2026 (estimated)
  4. Study completionJun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
Researchers will perform a randomized crossover study to compare system configurations with different number of sensor channels and with various strategies for sensor placement on the limb. Participants will be assigned to a random test sequence that includes the following four different EMG channel conditions: Condition A: 4 untargeted channels Condition B: 8 untargeted channels Condition C: Up to 16 untargeted channels Condition D: 8 targeted channels Researchers will evaluate the effects of changing myoelectric channel counts on the functional prosthesis performance of individuals with transradial limb loss via functional outcome measures. Additionally, participants will be asked to play virtual games with the Coapt EMG Cuff for 15 minutes a day, 3 days a week between visits. This arm is meant for practicing pattern recognition control and will not be compared between the other conditions or reported on.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07011420
Sponsor's protocol ID
00171879
Status last verified
Sep 2025
First submitted
15 May 2025
Last updated
3 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Experimental socket with 4 untargeted channels active, Experimental socket with 8 untargeted channels active and Experimental socket with up to 16 untargeted channels active in people with Amputation and Amputation, Traumatic, run by Liberating Technologies, Inc. at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Brianna Rozell (774-233-0876, brianna.rozell@liberatingtech.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Assessment of Capacity for Myoelectric Control (ACMC) (time frame: 4 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in